Crossmark

ASO Author Reflections: Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation of MMP-9

Crossref DOI link: https://doi.org/10.1245/s10434-022-12070-6

Published Online: 2022-06-29

Published Print: 2022-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yamanaka, Masaya

Hayashi, Masamichi

Kodera, Yasuhiro
Funding

Funding for this research was provided by:

the Japan Society for the Promotion of Science (JP19K18080)
License Information

Text and Data Mining valid from 2022-06-29

Version of Record valid from 2022-06-29
More Information

Article History

Received: 9 June 2022

Accepted: 12 June 2022

First Online: 29 June 2022

Disclosures

: Masaya Yamanaka, Masamichi Hayashi, and Yasuhiro Kodera have no conflicts of interest to disclose.

Document is current

Any future updates will be listed below